“A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants”
The primary objective of this study is to evaluate the safety and tolerability of single intravenous infusions of E2814 in healthy adult participants.
Drug - E2814
E2814, intravenous infusion.
Drug - E2814-matched placebo
E2814-matched placebo, intravenous infusion.
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of Intravenous Infusions of E2814 in Healthy Subjects